Treatment of eruptive lichen planus with oral acyclovir
DOI:
https://doi.org/10.66344/jpad.v30i1.1397Keywords:
Key Words, Lichen planus (LP), Hepatitis B virus(HBV), Hepatitis C virus(HCV), Diabetes mellitus (DM), Upper respiratory tract infection(URTI).Abstract
Objective To measure the efficacy of oral acyclovir for treatment of eruptive lichen planus.
Methods This quasi experimental study was done in outpatient department of Dermatology, Nishtar Medical University, Multan, from 01-05-2018 to 31-10-2018. Total thirty patients of eruptive lichen planus of either sex and age ranging from 18 – 65 years were included in this study. They were given oral acyclovir 400 mg three times a day for six weeks. Patients were followed up at three and six weeks and then up to three months to find out the efficacy of treatment.
Results A total of 30 patients were enrolled in the study with mean age of 37.76%±13.92. Males were 46.66% and females were 53.33%. 23 out of total 30 (76.7%) patients showed effective response to oral acyclovir.
Conclusion Oral Acyclovir is an effective and innovative treatment for eruptive lichen planus.
References
1. Hettiarachchi PV, Hettiarachchi RM, Jayasinghe RD, Sitheeque M. Comparison of topical tacrolimus and clobetasol in the management of symptomatic oral lichen planus: A double‐blinded, randomized clinical trial in Sri Lanka. J Investigative Clin Dent 2017; 8(4): e12237.
2. Georgescu SR, Mitran MI, Mitran CI, Sarbu MI, Nicolae I, Matei C, Caruntu C, Neagu M, Popa MI. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection. Exp Ther Med 2019; 17(2): 1045-51.
3. Alrashdan MS, Cirillo N, McCullough M. Oral lichen planus: a literature review and update. Arch Dermatol Res 2016; 308(8): 539-51.
4. Aamir S, Ullah Z, Iqbal Z, Khan AA, Yaqub F, Malik K. Cutaneous manifestations of interferon alfa and ribavirin for hepatitis C. J Pak Assoc Dermatol. 2016; 18(1): 14-20.
5. Ifeanyi OC, Akinboro AO, Ezejoifor IO, Onunu AN, Okwara BU. Epidemiologic and Clinical Differences Between Classic and Hypertrophic Lichen Planus in Nigeria. Serb J Dermatol Venereol. 2019; 11(1): 3-12.
6. Hieta N, Hiltunen-Back E. Human herpes virus 7 in a patient with recurrent vulvar ulceration. Actadermato-venereologica. 2016; 96(7): 1002-3.
7. Sajini L, Anjaneyan G, Jagadeesan S, Panicker VV, Sreedevan V, Gopakumar JT. Zero prevalence of hepatitis B and hepatitis C infections in clinicopathologically proven lichen planus cases: a cross sectional study at a tertiary care centre in South India. Int J Res Dermatol 2017; 3(3): 351-4.
8. Kazanowska-Dygdała M, Duś I, Radwan-Oczko M. The presence of Helicobacter pylori in oral cavities of patients with leukoplakia and oral lichen planus. J Applied Oral Sci 2016; 24(1): 18-23.
9. Mirza FN, Leonov A, Greydanus DE. Dermatological side effects to certain vaccines. J Pain Management 2016; 9(2): 147.
10. Pektas SD, Kutucularoglu E, Ozoguz P. The First Reported Adult Case of Lichen Planus following Rabies Vaccinatıon. Kuwait Med J 2017; 49(4): 340.
11. Murthy SA, Ballal S. Herpes Viruses. Comprehensive Approach to Infections in Dermatology 2016; 12: 203.
12. Jones J, Marquart JD, Logemann NF, DiBlasi DR. Lichen striatus-like eruption in an adult following hepatitis B vaccination: a case report and review of the literature. Dermatol Online J 2018; 24(7): 13030/qt1hr764kv.
13. Welz-Kubiak K, Reich A, Szepietowski JC. Clinical aspects of itch in lichen planus. Actadermato-venereologica 2017; 97(4): 505-8.
14. Al-Mutairi N, Joshi A, Zaki A, Sharma AK, Nour-Eldin O. Acute generalized lichen planus treated with weekly betamethasone 5-mg oral mini-pulse therapy. J Drugs Dermatol 2005; 4(2): 218–20.
15. Fleming J, Diaz-Cano S, Higgins E. Eruptive lichen planus triggered by acupuncture. Arch Dermatol 2011; 147(3): 361–2.
16. Khandpur S, Sugandhan S, Sharma VK. Pulsed itraconazole therapy in eruptive lichen planus. J Eur Acad Dermatol Venereol 2009; 23(1): 98–101.
17. Kanzaki T, Otake N, Nagai M. Eruptive lichen planus. J Dermatol 1992; 19(4):234–7.
18. Nahidi Y, TayyebiMeibodi N, Ghazvini K, Esmaily H, Esmaeelzadeh M. Association of classic lichen planus with humanherpesvirus-7 infection. Int J Dermatol 2017; 56, 49-53.
19. Nagao Y, Kimura K, Kawahigashi Y, Sata M. Successful treatment of hepatitis C virus-associated oral lichen planus by interferon-free therapy with direct-acting antivirals. Clin Translational Gastroenterol 2016; 7, e179.
20. Ganguly SA. randomized, double-blind, placebo-controlled study of efficacy of oral acyclovir in the treatment of pityriasisrosea. J Clin Diagnostic Res 2014; 8: YC01–YC04.
21. De Ruiter A, Thin RN. Genital herpes. A guide to pharmacological therapy. Drugs 1994; 47: 297–304.
22. Jackson JL, Gibbons R, Meyer G, Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis. Arch Internal Med 1997; 157: 909–912.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Aliya Akhtar, Nighat Fatima, Farah Sattar, Shazia Zubair, Sumara Rashid, Mehwish Saeed
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
